金色财经
金色财经|10月 20, 2026 23:10
[OpenAI Acquires Biopharmaceutical Research Platform Orchestra Bio] According to Golden Finance, on October 21, OpenAI has completed the acquisition of the biopharmaceutical research collaboration platform Orchestra Bio and will deeply integrate it with its existing life sciences AI research platform Rosalind.
+6
Mentioned
Share To

Timeline

HotFlash

APP

X

Telegram

Facebook

Reddit

CopyLink

Hot Reads